Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes

    Sanofi Winthrop and Bristol-Myers Squibb will soon promote Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes.

    It'll be out in the next few months in the U.S. and Canada.

    Plavix is a new platelet inhibitor. It's similar to Ticlid (ticlopidine)...but without the risk of neutropenia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote